4.7 Article

Primary immunodeficiencies: 2009 update

期刊

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 124, 期 6, 页码 1161-1178

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2009.10.013

关键词

Primary immunodeficiencies; T cells; B cells; severe combined immunodeficiency; predominantly antibody deficiencies; DNA repair defects; phagocytes; complement; immune dysregulation syndromes; innate immunity; autoinflammatory disorders

资金

  1. Jeffrey Modell Foundation
  2. National Institute of Allergy and Infectious Diseases [R13-AI-066891]
  3. National Institutes of Health [Al-35714]
  4. Baxter Healthcare
  5. Talecris
  6. Biotest
  7. Baxter Corp.
  8. March of Dimes
  9. European Community
  10. Swedish Research Council

向作者/读者索取更多资源

More than 50 years after Ogdeon Bruton's discovery of congenital agammaglobulinemia, human primary immunodeficiencies (PIDs) continue to unravel novel molecular and cellular mechanisms that govern development and function of the human immune system. This report provides the updated classification of PIDs that has been compiled by the International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies after its biannual meeting in Dublin, Ireland, in June 2009. Since the appearance of the last classification in 2007, novel forms of PID have been discovered, and additional pathophysiology mechanisms that account for PID in human beings have been unraveled. Careful analysis and prompt recognition of these disorders is essential to prompt effective forms of treatment and thus to improve survival and quality of life in patients affected with PIDs. (J Allergy Clin Immunol 2009;124:1161-78.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据